Longaeva Partners’s Hologic HOLX Stock Holding History

Longaeva Partners’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-149,000	Closed	-$10.1M	–	136
2025 Q3	$10.1M	Buy	+149,000	New	+$9.89M	1.45%	18

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Longaeva Partners's HOLX Position: Q4 2025 in Review

Longaeva Partners sold out of Hologic (HOLX) in Q4 2025, closing a stake of 614,934 shares — an estimated $41.5M sold.

Longaeva Partners first reported a position in HOLX in Q2 2025 and held it in 2 quarters. The position peaked at $41.5M in Q3 2025. 747 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

Longaeva Partners reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
Longaeva Partners sold 614,934 Hologic shares in Q4 2025, an estimated $41.5M.
Longaeva Partners first reported a position in Hologic in Q2 2025 and held it in 2 quarters.
Longaeva Partners's Hologic position peaked at $41.5M in Q3 2025.
747 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Longaeva Partners's 13F filing for Q4 2025, filed 17 Feb 2026.